Incyte INCY
NASDAQ INCY
$115.30 -1.84 (-1.57%)
At close: Oct 2, 2026 · 4:00 PM EDT

Incyte (INCY) Asset Writedowns and Impairment (2017)

Updated

Incyte (INCY) posted Asset Writedowns and Impairment of $76.3 million for FY2025.

Analysis

Incyte (INCY) Asset Writedowns and Impairment (2017) Analysis & Trends

Since FY2009, Incyte has reported Asset Writedowns and Impairment for 4 years.

  • Business Quant data shows INCY's Asset Writedowns and Impairment at $5.63 million in FY2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn
10 Incyte 23.17 Bn 8.11 Bn 1.57 Bn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2017 12.00 Mn
API Access

Incyte Asset Writedowns and Impairment API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=asset-writedowns-and-impairment&ticker=INCY&period=max&api_key=YOUR_API_KEY